Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The present study aimed to quantitatively assess the associations between vitamin D and Parkinson’s Disease (PD) risks, which include: (i) risk of PD in subjects with deficient and insufficient vitamin D levels; (ii) association between vitamin D supplementation and risk of PD; and (iii) association between outdoor work and PD risk, through meta-analyzing available data.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson’s Disease: A Meta-Analysis Assessment

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson’s Disease: A Meta-Analysis Assessment

Review / evidence synthesis · Nutrients · 2015

Original publication title

Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson’s Disease: A Meta-Analysis Assessment

Liang Shen; Hong-Fang Ji

© 2015 by the authors; licensee MDPI, Basel, Switzerland.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In conclusion, based on the eligible studies we found that low vitamin D level was associated with increased risk of PD, which is consistent with the hypothesis that low vitamin D status is a risk factor of PD. In addition, it was indicated that vitamin D supplementation and outdoor work may reduce PD risk. Thus, optimizing vitamin D level may represent a potential avenue for the prevention of PD. As only a few studies have investigated the effects of vitamin D supplementation against PD so far, further research on this issue is strongly encouraged.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Vitamin D is a fat-soluble steroid hormone, which is essential to maintain human health. In recent years, vitamin D has gained tremendous amount of attention owing to the reported associations between low vitamin D level and a wide range of chronic diseases, as well as the therapeutic potential of vitamin D supplementation for these diseases [1,2,3,4,5].

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in elders characterized by dysfunction and degeneration of dopaminergic neurons and the development of intraneuronal inclusions known as Lewy bodies [6,7]. The pathogenetic mechanism underlying PD is complex and remains far to be elucidated, while it is widely accepted that multiple genetic and environmental factors contribute to the development of PD [8,9]. Low vitamin D level has been found in patients with PD in recent years.

Since the first study by Sato et al. in 1997 [10], many studies found that PD patients had lower vitamin D level compared with controls, and the lower level of vitamin D than controls has been further comprehensively evaluated by meta-analyses [11,12,13]. In the present study, we attempted to quantitatively assess whether low vitamin D level predicts increased PD risk and the association of vitamin D supplementation and PD risk through meta-analyzing available data published so far.

As outdoor occupation can optimize vitamin D level due to exposure to solar ultraviolet B radiation, the association between outdoor work and PD risk was also investigated. The findings will provide important clues to the prevention of PD.

Source: 1. Introduction Source: 1. Introduction

Study methods

What methods does the paper describe?

2.1. Literature Search and Inclusion Criteria

We performed a literature search in the MEDLINE database from inception until March 2015 by using the following search terms: “Parkinson’s disease” and “vitamin D” or “25(OH)D”. To identify further potentially relevant studies missed by the search strategy, the reference lists of retrieved articles were also manually screened. A restriction to reference on human studies and those published in English is imposed during reference selection. The potentially eligible references were identified by reviewing titles and/or abstracts, and/or full text of all references obtained with literature search.

The inclusion criteria were as follows: (i) original studies investigated the associations of vitamin D level or vitamin D supplementation or outdoor work with PD risk; (ii) the odds ratios (ORs) or relative risks (RRs) with 95% confidence intervals (CI) of PD risk were provided or could be calculated.

2.2. Data Extraction and Statistical Analysis

Using prespecified data extraction tables, we extracted information from each eligible article about the study design, main characteristics of the study population, OR or RR and 95% CI of PD risk, and confounding factors that were adjusted during the analysis. If a study provided unadjusted and adjusted OR or RR, the most completely adjusted one was employed. Vitamin D deficiency and insufficiency were defined as serum 25-hydroxyvitamin D [25(OH)D], a stable marker of vitamin D status, concentrations of <50 nmol/L and <75 nmol/L, respectively [14].

Serum concentrations of 25(OH)D reported in ng/mL were converted to values in nmol/L by the conversion factor (1 ng/mL = 2.5 nmol/L). Two reviewers extracted the data from each study independently and consensus was obtained for the extracted data. Based on the extracted data, the OR and 95% CI of PD risk were calculated using the statistical software Stata version 12.0 for windows (StataCorp, College Station, TX, USA). All statistical analyses were performed using the random effect model and the statistical heterogeneity was evaluated through the I² statistic.

Source: 2. Methods Source: 2. Methods

Results: Results of the Literature Search

The literature selection and identification flow diagram was shown in Figure 1. Out of 149 initially identified references through database search, 35 were obtained for further screen after initial titles and/or abstracts screening. Following full text assessment 28 references were then excluded for being mechanistic studies or not providing enough data. Finally, seven eligible studies comprising 5690 PD patients and 21251 matched controls were identified, which formed the basis of the present analysis [15,16,17,18,19,20,21].

The seven studies are all observational studies and the years of publication ranged from 2008 to 2015. Among the seven studies, five were conducted in the USA, one in China, and one in Japan.

Figure 1

Flow diagram of literature search and identification of relevant studies.

Figure image at the original source: open the original paper. This file is not included in this text import.
Source: 3.1. Results of the Literature Search Source: 3.1. Results of the Literature Search

Assessment of Vitamin D Level and Risk of PD

Results / Results of Meta-analysis: Assessment of Vitamin D Level and Risk of PD

Three studies covering 966 PD patients and 813 age-matched controls were included in the quantitative analysis of vitamin D level and risk of PD [15,16,17]. Main descriptive data from the studies are shown in Table 1. Results of the meta-analysis revealed that low vitamin D level was associated with significantly increased risk of PD overall according to the OR: 1.50, 95% CI: 1.31 to 1.71. Vitamin D deficient individuals (serum 25(OH)D level <50 nmol/L) had a two-fold increased risk of PD in comparison with controls OR: 2.08, 95% CI: 1.63 to 2.65, and vitamin D insufficient individuals (serum 25(OH)D level <75 nmol/L) experienced a 30% increased risk of PD compared with controls (OR: 1.29, 95% CI: 1.10 to 1.51) (Figure 2).

There was no evidence for significant statistical heterogeneity between the eligible studies.

Figure 2

Forest plots of deficient and insufficient vitamin D levels and risk of Parkinson’s Disease (PD).

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Main characteristics of eligible studies for the analysis of vitamin D deficiency and risk of PD.

ReferencesYearCountryStudy TypeNumber of ParticipantsAverage Age (years)OR (95% CI) *Adjustments
PDControlPDControl
Evatt [15]2008USAcohort1009965.465.72.28 (1.03, 5.03)
(deficient)
1.51 (0.91, 2.50)
(insufficient)
age, sex, race, symptom duration, and sampling season
Ding [16]2013USAcross-sectional and case-control38828365.7 ± 9.68.0 ± 10.41.91 (1.18, 3.07)
(deficient)
1.19 (0.90, 1.57)
(insufficient)
age, sex, race, and vitamin D supplementation
Wang [17]2015USAcase-control47843164 ± 1270 ± 82.12 (1.57, 2.88)
(deficient)
1.31 (1.06, 1.62)
(insufficient)
age, sex, and sampling season

* To unify the data OR and 95% CI were calculated using Stata according to the corresponding events and total numbers in PD and controls groups of eligible studies.

Source: 3.2.1. Assessment of Vitamin D Level and Risk of PD Source: 3.2.1. Assessment of Vitamin D Level and Risk of PD Source: 3.2.1. Assessment of Vitamin D Level and Risk of PD

Assessment of Vitamin D Supplementation and Risk of PD

Results / Results of Meta-analysis: Assessment of Vitamin D Supplementation and Risk of PD

Two case-control studies covering 458 patients with PD and 578 cases were included in the assessment of association between vitamin D supplementation and PD risk and the main descriptive data from the studies are shown in Table 2 [18,19]. As shown in Figure 3, the calculated OR for comparison of the highest with the lowest vitamin D supplementation was 0.62, 95% CI 0.35 to 0.90. This indicated that vitamin D supplementation was associated with a decreased risk of developing PD by 38%.

No evidence for significant statistical heterogeneity was observed between the eligible studies.

Figure 3

Forest plots of vitamin D supplementation and risk of PD.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 2

Main characteristics of eligible studies for the analysis of vitamin D supplementation, outdoor work and risk of PD.

ReferencesYearCountryStudy TypeParticipantsAverage Age (years)OR, 95% CI High Versus Low CategoryAdjustments
PDControlPDControl
Vitamin D supplementation
Miyake [18]2011Japancase-control24936868.566.60.82 (0.46 to 1.47)age, sex, region of residence, pack-years of smoking, years of education, body mass index and dietary factors including cholesterol, dietary glycemic index, vitamin E, β-carotene, vitamin B6, caffeine, iron, and alcohol
Zhu [19]2014Chinacase-control20921064.6 ± 9.466.0 ± 8.10.54 (0.30 to 0.96)age, sex, smoking, alcohol use, education, and BMI
Outdoor work
Kenborg [20]2011USAcase-control381919,28271.2-0.72 (0.63 to 0.82)age, chronic obstructive pulmonary disease, comorbidity, place of birth, and social class
Kwon [21]2013USAcase-control44757866680.74 (0.44 to 1.25)age, sex, and smoking
Source: 3.2.2. Assessment of Vitamin D Supplementation and Risk of PD Source: 3.2.2. Assessment of Vitamin D Supplementation and Risk of PD Source: 3.2.2. Assessment of Vitamin D Supplementation and Risk of PD

Assessment of Outdoor Work and Risk of PD

Results / Results of Meta-analysis: Assessment of Outdoor Work and Risk of PD

There were 4266 PD patients and 19860 controls included in two eligible case-controls studies about the association of outdoor work and risk of PD [20,21]. Table 2 lists the main descriptive data from the eligible studies. A statistically significant inverse relation was found between outdoor work and risk of PD according to the pooled OR: 0.72, 95% CI: 0.63 to 0.81 (Figure 4), and there was no evidence for significant statistical heterogeneity.

Figure 4

Forest plots of outdoor work and risk of PD.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Main characteristics of eligible studies for the analysis of vitamin D deficiency and risk of PD.

ReferencesYearCountryStudy TypeNumber of ParticipantsAverage Age (years)OR (95% CI) *Adjustments
PDControlPDControl
Evatt [15]2008USAcohort1009965.465.72.28 (1.03, 5.03)
(deficient)
1.51 (0.91, 2.50)
(insufficient)
age, sex, race, symptom duration, and sampling season
Ding [16]2013USAcross-sectional and case-control38828365.7 ± 9.68.0 ± 10.41.91 (1.18, 3.07)
(deficient)
1.19 (0.90, 1.57)
(insufficient)
age, sex, race, and vitamin D supplementation
Wang [17]2015USAcase-control47843164 ± 1270 ± 82.12 (1.57, 2.88)
(deficient)
1.31 (1.06, 1.62)
(insufficient)
age, sex, and sampling season

* To unify the data OR and 95% CI were calculated using Stata according to the corresponding events and total numbers in PD and controls groups of eligible studies.

Table 2

Main characteristics of eligible studies for the analysis of vitamin D supplementation, outdoor work and risk of PD.

ReferencesYearCountryStudy TypeParticipantsAverage Age (years)OR, 95% CI High Versus Low CategoryAdjustments
PDControlPDControl
Vitamin D supplementation
Miyake [18]2011Japancase-control24936868.566.60.82 (0.46 to 1.47)age, sex, region of residence, pack-years of smoking, years of education, body mass index and dietary factors including cholesterol, dietary glycemic index, vitamin E, β-carotene, vitamin B6, caffeine, iron, and alcohol
Zhu [19]2014Chinacase-control20921064.6 ± 9.466.0 ± 8.10.54 (0.30 to 0.96)age, sex, smoking, alcohol use, education, and BMI
Outdoor work
Kenborg [20]2011USAcase-control381919,28271.2-0.72 (0.63 to 0.82)age, chronic obstructive pulmonary disease, comorbidity, place of birth, and social class
Kwon [21]2013USAcase-control44757866680.74 (0.44 to 1.25)age, sex, and smoking
Source: 3.2.3. Assessment of Outdoor Work and Risk of PD Source: 3.2.3. Assessment of Outdoor Work and Risk of PD Source: 3.2.3. Assessment of Outdoor Work and Risk of PD Source: 3.2.3. Assessment of Outdoor Work and Risk of PD

Discussion

Vitamin D is obtained through the diet and is photosynthesized in the skin upon exposure to solar ultraviolet B radiation. Vitamin D deficiency has been found to be associated with various chronic diseases conditions, such as cancer, cardiovascular diseases, diabetes, stroke, and neurodegenerative diseases, which aroused much interest for the potential of vitamin D in prevention and intervention of these disorders in recent years [1,2,3,4,5]. The lower vitamin D level in patients with PD compared with age-matched controls has been widely investigated [10,11,12,13,14].

Previous meta-analyses have consistently found that PD patients had lower levels of vitamin D than controls [11,12,13,14], while the associations between vitamin D status, supplementation, outdoor work and risk of PD merit to be further evaluated. To further comprehensively explore the association between vitamin D and PD, the present meta-analysis was designed to quantitatively assess the associations between vitamin D level and risk of PD, and vitamin D supplementation and outdoor work in lowering PD risk.

Pooled data showed that subjects with deficient vitamin D level (25(OH)D < 50 nmol/L) experienced a two folds of PD risk (OR: 2.08, 95% CI: 1.63 to 2.65), and vitamin D insufficient subjects (25(OH)D < 75 nmol/L) also have increased PD risk according to the corresponding OR: 1.29, 95% CI: 1.10 to 1.51. This is in line with the suggestion that high vitamin D level exhibits protective effects against PD [22]. Both vitamin D supplementation and outdoor work were associated with a significantly reduced risk of PD indicated by the respective calculated OR: 0.62, 95% CI: 0.35 to 0.90, and OR: 0.72, 95% CI: 0.63 to 0.81.

The possible biological underpinning underlying the association between vitamin D level and PD risk should be multiple. First, as the primary mediator of vitamin D’s biological actions, the vitamin D receptor (VDR) exhibits multiple genetic polymorphisms, and many studies have reported the association between VDR polymorphisms and risk of PD [23,24,25]. Second, as oxidative stress contributes to the pathogenesis of PD [26], the attenuated antioxidant capacity of reduced level of vitamin D may increase the risk of PD.

Third, vitamin D has been revealed to be crucial to active human T cells and vitamin D deficiency may prohibit T cell from clearing the insoluble α-synuclein fibrils and thus, may increase the PD risks [27,28]. Certainly, the mechanisms underlying the association between vitamin D level and PD risk is not limited to the above aspects and can be enriched by more mechanistic studies.

Pooled results of the meta-analysis should be considered in the context of its limitations. First, the number of the eligible studies and covered participants was relatively small. Second, the vitamin D supplementation and out-door activity are based on self-administered diet history questionnaire and self-report questionnaire. The confounders for which adjustments are made also varied in each study. These factors will potentially affect the results. Third, the potential effects of anti-PD drugs cannot be explicitly considered in the included studies. Fourth, due to the limited eligible studies we cannot perform gender and ethnic subgroup analysis.

Source: 4. Discussion Source: 4. Discussion Source: 4. Discussion

Results

3.1. Results of the Literature Search

The literature selection and identification flow diagram was shown in Figure 1. Out of 149 initially identified references through database search, 35 were obtained for further screen after initial titles and/or abstracts screening. Following full text assessment 28 references were then excluded for being mechanistic studies or not providing enough data. Finally, seven eligible studies comprising 5690 PD patients and 21251 matched controls were identified, which formed the basis of the present analysis [15,16,17,18,19,20,21].

The seven studies are all observational studies and the years of publication ranged from 2008 to 2015. Among the seven studies, five were conducted in the USA, one in China, and one in Japan.

Figure 1

Flow diagram of literature search and identification of relevant studies.

Figure image at the original source: open the original paper. This file is not included in this text import.

3.2. Results of Meta-analysis

3.2.1. Assessment of Vitamin D Level and Risk of PD

Three studies covering 966 PD patients and 813 age-matched controls were included in the quantitative analysis of vitamin D level and risk of PD [15,16,17]. Main descriptive data from the studies are shown in Table 1. Results of the meta-analysis revealed that low vitamin D level was associated with significantly increased risk of PD overall according to the OR: 1.50, 95% CI: 1.31 to 1.71. Vitamin D deficient individuals (serum 25(OH)D level <50 nmol/L) had a two-fold increased risk of PD in comparison with controls OR: 2.08, 95% CI: 1.63 to 2.65, and vitamin D insufficient individuals (serum 25(OH)D level <75 nmol/L) experienced a 30% increased risk of PD compared with controls (OR: 1.29, 95% CI: 1.10 to 1.51) (Figure 2).

There was no evidence for significant statistical heterogeneity between the eligible studies.

Figure 2

Forest plots of deficient and insufficient vitamin D levels and risk of Parkinson’s Disease (PD).

Figure image at the original source: open the original paper. This file is not included in this text import.
3.2.2. Assessment of Vitamin D Supplementation and Risk of PD

Two case-control studies covering 458 patients with PD and 578 cases were included in the assessment of association between vitamin D supplementation and PD risk and the main descriptive data from the studies are shown in Table 2 [18,19]. As shown in Figure 3, the calculated OR for comparison of the highest with the lowest vitamin D supplementation was 0.62, 95% CI 0.35 to 0.90. This indicated that vitamin D supplementation was associated with a decreased risk of developing PD by 38%.

No evidence for significant statistical heterogeneity was observed between the eligible studies.

Figure 3

Forest plots of vitamin D supplementation and risk of PD.

Figure image at the original source: open the original paper. This file is not included in this text import.
3.2.3. Assessment of Outdoor Work and Risk of PD

There were 4266 PD patients and 19860 controls included in two eligible case-controls studies about the association of outdoor work and risk of PD [20,21]. Table 2 lists the main descriptive data from the eligible studies. A statistically significant inverse relation was found between outdoor work and risk of PD according to the pooled OR: 0.72, 95% CI: 0.63 to 0.81 (Figure 4), and there was no evidence for significant statistical heterogeneity.

Figure 4

Forest plots of outdoor work and risk of PD.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Main characteristics of eligible studies for the analysis of vitamin D deficiency and risk of PD.

ReferencesYearCountryStudy TypeNumber of ParticipantsAverage Age (years)OR (95% CI) *Adjustments
PDControlPDControl
Evatt [15]2008USAcohort1009965.465.72.28 (1.03, 5.03)
(deficient)
1.51 (0.91, 2.50)
(insufficient)
age, sex, race, symptom duration, and sampling season
Ding [16]2013USAcross-sectional and case-control38828365.7 ± 9.68.0 ± 10.41.91 (1.18, 3.07)
(deficient)
1.19 (0.90, 1.57)
(insufficient)
age, sex, race, and vitamin D supplementation
Wang [17]2015USAcase-control47843164 ± 1270 ± 82.12 (1.57, 2.88)
(deficient)
1.31 (1.06, 1.62)
(insufficient)
age, sex, and sampling season

* To unify the data OR and 95% CI were calculated using Stata according to the corresponding events and total numbers in PD and controls groups of eligible studies.

Table 2

Main characteristics of eligible studies for the analysis of vitamin D supplementation, outdoor work and risk of PD.

ReferencesYearCountryStudy TypeParticipantsAverage Age (years)OR, 95% CI High Versus Low CategoryAdjustments
PDControlPDControl
Vitamin D supplementation
Miyake [18]2011Japancase-control24936868.566.60.82 (0.46 to 1.47)age, sex, region of residence, pack-years of smoking, years of education, body mass index and dietary factors including cholesterol, dietary glycemic index, vitamin E, β-carotene, vitamin B6, caffeine, iron, and alcohol
Zhu [19]2014Chinacase-control20921064.6 ± 9.466.0 ± 8.10.54 (0.30 to 0.96)age, sex, smoking, alcohol use, education, and BMI
Outdoor work
Kenborg [20]2011USAcase-control381919,28271.2-0.72 (0.63 to 0.82)age, chronic obstructive pulmonary disease, comorbidity, place of birth, and social class
Kwon [21]2013USAcase-control44757866680.74 (0.44 to 1.25)age, sex, and smoking
Source: 3. Results Source: 3. Results

Conclusions

In conclusion, based on the eligible studies we found that low vitamin D level was associated with increased risk of PD, which is consistent with the hypothesis that low vitamin D status is a risk factor of PD. In addition, it was indicated that vitamin D supplementation and outdoor work may reduce PD risk. Thus, optimizing vitamin D level may represent a potential avenue for the prevention of PD. As only a few studies have investigated the effects of vitamin D supplementation against PD so far, further research on this issue is strongly encouraged.

Source: 5. Conclusions
Authors’ abstract

The present study aimed to quantitatively assess the associations between vitamin D and Parkinson’s Disease (PD) risks, which include: (i) risk of PD in subjects with deficient and insufficient vitamin D levels; (ii) association between vitamin D supplementation and risk of PD; and (iii) association between outdoor work and PD risk, through meta-analyzing available data. An electronic literature search supplemented by hand searching up to March 2015 identified seven eligible studies comprising 5690 PD patients and 21251 matched controls. Odds ratio (OR) and 95% confidence interval (CI) of PD risk were assessed through pooling the collected data from eligible studies using Stata software.

Pooled data showed that subjects with deficient and insufficient vitamin D levels had increased PD risks compared with matched-controls according to the corresponding OR: 2.08, 95% CI: 1.63 to 2.65, and 1.29, 95% CI: 1.10 to 1.51. Vitamin D supplementation was associated with significantly reduced risk of PD (OR: 0.62, 95% CI: 0.35 to 0.90). Outdoor work was also related to reduced risk of PD (OR: 0.72, 95% CI: 0.63 to 0.81). The findings may stimulate larger, well-designed studies to further verify the associations between vitamin D and PD risk.

Read the full paper

1. Introduction

Vitamin D is a fat-soluble steroid hormone, which is essential to maintain human health. In recent years, vitamin D has gained tremendous amount of attention owing to the reported associations between low vitamin D level and a wide range of chronic diseases, as well as the therapeutic potential of vitamin D supplementation for these diseases [1,2,3,4,5].

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in elders characterized by dysfunction and degeneration of dopaminergic neurons and the development of intraneuronal inclusions known as Lewy bodies [6,7]. The pathogenetic mechanism underlying PD is complex and remains far to be elucidated, while it is widely accepted that multiple genetic and environmental factors contribute to the development of PD [8,9]. Low vitamin D level has been found in patients with PD in recent years.

Since the first study by Sato et al. in 1997 [10], many studies found that PD patients had lower vitamin D level compared with controls, and the lower level of vitamin D than controls has been further comprehensively evaluated by meta-analyses [11,12,13]. In the present study, we attempted to quantitatively assess whether low vitamin D level predicts increased PD risk and the association of vitamin D supplementation and PD risk through meta-analyzing available data published so far.

As outdoor occupation can optimize vitamin D level due to exposure to solar ultraviolet B radiation, the association between outdoor work and PD risk was also investigated. The findings will provide important clues to the prevention of PD.

2. Methods

2.1. Literature Search and Inclusion Criteria

We performed a literature search in the MEDLINE database from inception until March 2015 by using the following search terms: “Parkinson’s disease” and “vitamin D” or “25(OH)D”. To identify further potentially relevant studies missed by the search strategy, the reference lists of retrieved articles were also manually screened. A restriction to reference on human studies and those published in English is imposed during reference selection. The potentially eligible references were identified by reviewing titles and/or abstracts, and/or full text of all references obtained with literature search.

The inclusion criteria were as follows: (i) original studies investigated the associations of vitamin D level or vitamin D supplementation or outdoor work with PD risk; (ii) the odds ratios (ORs) or relative risks (RRs) with 95% confidence intervals (CI) of PD risk were provided or could be calculated.

2.2. Data Extraction and Statistical Analysis

Using prespecified data extraction tables, we extracted information from each eligible article about the study design, main characteristics of the study population, OR or RR and 95% CI of PD risk, and confounding factors that were adjusted during the analysis. If a study provided unadjusted and adjusted OR or RR, the most completely adjusted one was employed. Vitamin D deficiency and insufficiency were defined as serum 25-hydroxyvitamin D [25(OH)D], a stable marker of vitamin D status, concentrations of <50 nmol/L and <75 nmol/L, respectively [14].

Serum concentrations of 25(OH)D reported in ng/mL were converted to values in nmol/L by the conversion factor (1 ng/mL = 2.5 nmol/L). Two reviewers extracted the data from each study independently and consensus was obtained for the extracted data. Based on the extracted data, the OR and 95% CI of PD risk were calculated using the statistical software Stata version 12.0 for windows (StataCorp, College Station, TX, USA). All statistical analyses were performed using the random effect model and the statistical heterogeneity was evaluated through the I² statistic.

3. Results

3.1. Results of the Literature Search

The literature selection and identification flow diagram was shown in Figure 1. Out of 149 initially identified references through database search, 35 were obtained for further screen after initial titles and/or abstracts screening. Following full text assessment 28 references were then excluded for being mechanistic studies or not providing enough data. Finally, seven eligible studies comprising 5690 PD patients and 21251 matched controls were identified, which formed the basis of the present analysis [15,16,17,18,19,20,21].

The seven studies are all observational studies and the years of publication ranged from 2008 to 2015. Among the seven studies, five were conducted in the USA, one in China, and one in Japan.

Figure 1

Flow diagram of literature search and identification of relevant studies.

Figure image at the original source: open the original paper. This file is not included in this text import.

3.2. Results of Meta-analysis

3.2.1. Assessment of Vitamin D Level and Risk of PD

Three studies covering 966 PD patients and 813 age-matched controls were included in the quantitative analysis of vitamin D level and risk of PD [15,16,17]. Main descriptive data from the studies are shown in Table 1. Results of the meta-analysis revealed that low vitamin D level was associated with significantly increased risk of PD overall according to the OR: 1.50, 95% CI: 1.31 to 1.71. Vitamin D deficient individuals (serum 25(OH)D level <50 nmol/L) had a two-fold increased risk of PD in comparison with controls OR: 2.08, 95% CI: 1.63 to 2.65, and vitamin D insufficient individuals (serum 25(OH)D level <75 nmol/L) experienced a 30% increased risk of PD compared with controls (OR: 1.29, 95% CI: 1.10 to 1.51) (Figure 2).

There was no evidence for significant statistical heterogeneity between the eligible studies.

Figure 2

Forest plots of deficient and insufficient vitamin D levels and risk of Parkinson’s Disease (PD).

Figure image at the original source: open the original paper. This file is not included in this text import.
3.2.2. Assessment of Vitamin D Supplementation and Risk of PD

Two case-control studies covering 458 patients with PD and 578 cases were included in the assessment of association between vitamin D supplementation and PD risk and the main descriptive data from the studies are shown in Table 2 [18,19]. As shown in Figure 3, the calculated OR for comparison of the highest with the lowest vitamin D supplementation was 0.62, 95% CI 0.35 to 0.90. This indicated that vitamin D supplementation was associated with a decreased risk of developing PD by 38%.

No evidence for significant statistical heterogeneity was observed between the eligible studies.

Figure 3

Forest plots of vitamin D supplementation and risk of PD.

Figure image at the original source: open the original paper. This file is not included in this text import.
3.2.3. Assessment of Outdoor Work and Risk of PD

There were 4266 PD patients and 19860 controls included in two eligible case-controls studies about the association of outdoor work and risk of PD [20,21]. Table 2 lists the main descriptive data from the eligible studies. A statistically significant inverse relation was found between outdoor work and risk of PD according to the pooled OR: 0.72, 95% CI: 0.63 to 0.81 (Figure 4), and there was no evidence for significant statistical heterogeneity.

Figure 4

Forest plots of outdoor work and risk of PD.

Figure image at the original source: open the original paper. This file is not included in this text import.
Table 1

Main characteristics of eligible studies for the analysis of vitamin D deficiency and risk of PD.

ReferencesYearCountryStudy TypeNumber of ParticipantsAverage Age (years)OR (95% CI) *Adjustments
PDControlPDControl
Evatt [15]2008USAcohort1009965.465.72.28 (1.03, 5.03)
(deficient)
1.51 (0.91, 2.50)
(insufficient)
age, sex, race, symptom duration, and sampling season
Ding [16]2013USAcross-sectional and case-control38828365.7 ± 9.68.0 ± 10.41.91 (1.18, 3.07)
(deficient)
1.19 (0.90, 1.57)
(insufficient)
age, sex, race, and vitamin D supplementation
Wang [17]2015USAcase-control47843164 ± 1270 ± 82.12 (1.57, 2.88)
(deficient)
1.31 (1.06, 1.62)
(insufficient)
age, sex, and sampling season

* To unify the data OR and 95% CI were calculated using Stata according to the corresponding events and total numbers in PD and controls groups of eligible studies.

Table 2

Main characteristics of eligible studies for the analysis of vitamin D supplementation, outdoor work and risk of PD.

ReferencesYearCountryStudy TypeParticipantsAverage Age (years)OR, 95% CI High Versus Low CategoryAdjustments
PDControlPDControl
Vitamin D supplementation
Miyake [18]2011Japancase-control24936868.566.60.82 (0.46 to 1.47)age, sex, region of residence, pack-years of smoking, years of education, body mass index and dietary factors including cholesterol, dietary glycemic index, vitamin E, β-carotene, vitamin B6, caffeine, iron, and alcohol
Zhu [19]2014Chinacase-control20921064.6 ± 9.466.0 ± 8.10.54 (0.30 to 0.96)age, sex, smoking, alcohol use, education, and BMI
Outdoor work
Kenborg [20]2011USAcase-control381919,28271.2-0.72 (0.63 to 0.82)age, chronic obstructive pulmonary disease, comorbidity, place of birth, and social class
Kwon [21]2013USAcase-control44757866680.74 (0.44 to 1.25)age, sex, and smoking

4. Discussion

Vitamin D is obtained through the diet and is photosynthesized in the skin upon exposure to solar ultraviolet B radiation. Vitamin D deficiency has been found to be associated with various chronic diseases conditions, such as cancer, cardiovascular diseases, diabetes, stroke, and neurodegenerative diseases, which aroused much interest for the potential of vitamin D in prevention and intervention of these disorders in recent years [1,2,3,4,5]. The lower vitamin D level in patients with PD compared with age-matched controls has been widely investigated [10,11,12,13,14].

Previous meta-analyses have consistently found that PD patients had lower levels of vitamin D than controls [11,12,13,14], while the associations between vitamin D status, supplementation, outdoor work and risk of PD merit to be further evaluated. To further comprehensively explore the association between vitamin D and PD, the present meta-analysis was designed to quantitatively assess the associations between vitamin D level and risk of PD, and vitamin D supplementation and outdoor work in lowering PD risk.

Pooled data showed that subjects with deficient vitamin D level (25(OH)D < 50 nmol/L) experienced a two folds of PD risk (OR: 2.08, 95% CI: 1.63 to 2.65), and vitamin D insufficient subjects (25(OH)D < 75 nmol/L) also have increased PD risk according to the corresponding OR: 1.29, 95% CI: 1.10 to 1.51. This is in line with the suggestion that high vitamin D level exhibits protective effects against PD [22]. Both vitamin D supplementation and outdoor work were associated with a significantly reduced risk of PD indicated by the respective calculated OR: 0.62, 95% CI: 0.35 to 0.90, and OR: 0.72, 95% CI: 0.63 to 0.81.

The possible biological underpinning underlying the association between vitamin D level and PD risk should be multiple. First, as the primary mediator of vitamin D’s biological actions, the vitamin D receptor (VDR) exhibits multiple genetic polymorphisms, and many studies have reported the association between VDR polymorphisms and risk of PD [23,24,25]. Second, as oxidative stress contributes to the pathogenesis of PD [26], the attenuated antioxidant capacity of reduced level of vitamin D may increase the risk of PD.

Third, vitamin D has been revealed to be crucial to active human T cells and vitamin D deficiency may prohibit T cell from clearing the insoluble α-synuclein fibrils and thus, may increase the PD risks [27,28]. Certainly, the mechanisms underlying the association between vitamin D level and PD risk is not limited to the above aspects and can be enriched by more mechanistic studies.

Pooled results of the meta-analysis should be considered in the context of its limitations. First, the number of the eligible studies and covered participants was relatively small. Second, the vitamin D supplementation and out-door activity are based on self-administered diet history questionnaire and self-report questionnaire. The confounders for which adjustments are made also varied in each study. These factors will potentially affect the results. Third, the potential effects of anti-PD drugs cannot be explicitly considered in the included studies. Fourth, due to the limited eligible studies we cannot perform gender and ethnic subgroup analysis.

5. Conclusions

In conclusion, based on the eligible studies we found that low vitamin D level was associated with increased risk of PD, which is consistent with the hypothesis that low vitamin D status is a risk factor of PD. In addition, it was indicated that vitamin D supplementation and outdoor work may reduce PD risk. Thus, optimizing vitamin D level may represent a potential avenue for the prevention of PD. As only a few studies have investigated the effects of vitamin D supplementation against PD so far, further research on this issue is strongly encouraged.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (Grant No. 31370745) and Shandong Provincial Natural Science Foundation (Grant No. ZR2014CL008).

Author Contributions

Hong-Fang Ji conceived and designed the experiments; Liang Shen and Hong-Fang Ji collected the data, performed the analysis. Liang Shen and Hong-Fang Ji analyzed the results. Liang Shen and Hong-Fang Ji wrote the paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

1. Gröber U. Spitz J. Reichrath J. Kisters K. Holick M.F. Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare Dermatoendocrinology 2013 5 331 347 10.4161/derm.26738 24516687 PMC3908963
2. Vacek J.L. Vanga S.R. Good M. Lai S.M. Lakkireddy D. Howard P.A. Vitamin D deficiency and supplementation and relation to cardiovascular health Am. J. Cardiol. 2012 109 359 363 10.1016/j.amjcard.2011.09.020 22071212
3. Wacker M. Holick M.F. Sunlight and Vitamin D: A global perspective for health Dermatoendocrinology 2013 5 51 108 10.4161/derm.24494 24494042 PMC3897598
4. Bolland M.J. Grey A. Gamble G.D. Reid I.R. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-analysis Lancet Diabetes Endocrinol. 2014 2 307 320 10.1016/S2213-8587(13)70212-2 24703049
5. Garcion E. Wion-Barbot N. Montero-Menei C.N. Berger F. Wion D. New clues about vitamin D functions in the nervous system Trends Endocrinol. Metab. 2002 13 100 105 10.1016/S1043-2760(01)00547-1 11893522
6. Chaudhuri K.R. Healy D.G. Schapira A.H. Non-motor symptoms of Parkinson’s disease: Diagnosis and management Lancet Neurol. 2006 5 235 245 10.1016/S1474-4422(06)70373-8 16488379
7. Braak H. Del Tredici K. Invited Article: Nervous system pathology in sporadic Parkinson disease Neurology 2008 70 1916 1925 10.1212/01.wnl.0000312279.49272.9f 18474848
8. Dick F.D. de P.G. Ahmadi A. Scott N.W. Prescott G.J. Bennett J. Semple S. Dick S. Counsell C. Mozzoni P. Environmental risk factors for Parkinson’s disease and parkinsonism: The Geoparkinson study Occup. Environ. Med. 2007 64 666 672 10.1136/oem.2006.027003 17332139 PMC2078401
9. Dardiotis E. Xiromerisiou G. Hadjichristodoulou C. Tsatsakis A.M. Wilks M.F. Hadjigeorgiou G.M. The interplay between environmental and genetic factors in Parkinson’s disease susceptibility: The evidence for pesticides Toxicology 2013 307 17 23 10.1016/j.tox.2012.12.016 23295711
10. Sato Y. Kikuyama M. Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson’s disease Neurology 1997 49 1273 1278 10.1212/WNL.49.5.1273 9371907
11. Van den Bos F. Speelman A.D. van Nimwegen M. van der Schouw Y.T. Backx F.J. Bloem B.R. Munneke M. Verhaar H.J. Bone mineral density and vitamin D status in Parkinson’s disease patients J. Neurol. 2013 260 754 760 23052606 10.1007/s00415-012-6697-x
12. Zhao Y. Sun Y. Ji H.F. Shen L. Vitamin D levels in Alzheimer’s and Parkinson’s diseases: A meta-analysis Nutrition 2013 29 828 832 10.1016/j.nut.2012.11.018 23415143
13. Lv Z. Qi H. Wang L. Fan X. Han F. Wang H. Bi S. Vitamin D status and Parkinson’s disease: A systematic review and meta-analysis Neurol. Sci. 2014 35 1723 1730 10.1007/s10072-014-1821-6 24847960
14. Holick M.F. Vitamin D deficiency N. Engl. J. Med. 2007 357 266 281 10.1056/NEJMra070553 17634462
15. Evatt M.L. Delong M.R. Khazai N. Rosen A. Triche S. Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease Arch. Neurol. 2008 65 1348 1352 10.1001/archneur.65.10.1348 18852350 PMC2746037
16. Ding H. Dhima K. Lockhart K.C. Locascio J.J. Hoesing A.N. Duong K. Trisini-Lipsanopoulos A. Hayes M.T. Sohur U.S. Wills A.M. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study Neurology 2013 81 1531 1537 10.1212/WNL.0b013e3182a95818 24068787 PMC3888173
17. Wang L. Evatt M.L. Maldonado L.G. Perry W.R. Ritchie J.C. Beecham G.W. Martin E.R. Haines J.L. Pericak-Vance M.A. Vance J.M. Vitamin D from different sources is inversely associated with Parkinson disease Mov. Disord. 2015 30 560 566 10.1002/mds.26117 25545356 PMC4390412
18. Miyake Y. Tanaka K. Fukushima W. Sasaki S. Kiyohara C. Tsuboi Y. Yamada T. Oeda T. Miki T. Kawamura N. Lack of association of dairy food, calcium, and vitamin D intake with the risk of Parkinson’s disease: A case-control study in Japan. Parkinsonism Relat. Disord. 2011 17 112 116 10.1016/j.parkreldis.2010.11.018 21169048
19. Zhu D. Liu G.Y. Lv Z. Wen S.R. Bi S. Wang W.Z. Inverse associations of outdoor activity and vitamin D intake with the risk of Parkinson’s disease J. Zhejiang Univ. Sci. B 2014 15 923 927 10.1631/jzus.B1400005 25294382 PMC4201321
20. Kenborg L. Lassen C.F. Ritz B. Schernhammer E.S. Hansen J. Gatto N.M. Olsen J.H. Outdoor work and risk for Parkinson’s disease: A population-based case-control study Occup. Environ. Med. 2011 68 273 278 10.1136/oem.2010.057448 20884793 PMC3667158
21. Kwon E. Gallagher L.G. Searles Nielsen S. Franklin G.M. Littell C.T. Longstreth W.T. Jr. Swanson P.D. Checkoway H. Parkinson’s disease and history of outdoor occupation Parkinsonism Relat. Disord. 2013 19 1164 1166 10.1016/j.parkreldis.2013.08.014 24044947 PMC3927788
22. Knekt P. Kilkkinen A. Rissanen H. Marniemi J. Säksjärvi K. Heliövaara M. Serum vitamin D and the risk of Parkinson disease Arch. Neurol. 2010 67 808 811 10.1001/archneurol.2010.120 20625085 PMC3091074
23. Butler M.W. Burt A. Edwards T.L. Zuchner S. Scott W.K. Martin E.R. Vance J.M. Wang L. Vitamin D receptor gene as a candidate gene for Parkinson disease Ann. Hum. Genet. 2011 75 201 210 10.1111/j.1469-1809.2010.00631.x 21309754 PMC3077063
24. Lin C.H. Chen K.H. Chen M.L. Lin H.I. Wu R.M. Vitamin D receptor genetic variants and Parkinson’s disease in a Taiwanese population Neurobiol. Aging 2014 35 1212.e11 1212.e13 10.1016/j.neurobiolaging.2013.10.094 24239437
25. Török R. Török N. Szalardy L. Plangar I. Szolnoki Z. Somogyvari F. Vecsei L. Klivenyi P. Association of vitamin D receptor gene polymorphisms and Parkinson’s disease in Hungarians Neurosci. Lett. 2013 551 70 74 10.1016/j.neulet.2013.07.014 23880018
26. Henchcliffe C. Beal M.F. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis Nat. Clin. Pract. Neurol. 2008 4 600 609 10.1038/ncpneuro0924 18978800
27. Von Essen M.R. Kongsbak M. Schjerling P. Olgaard K. Odum N. Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells Nat. Immunol. 2010 11 344 349 10.1038/ni.1851 20208539
28. Høyer-Hansen M. Nordbrandt S.P. Jäättelä M. Autophagy as a basis for the health-promoting effects of vitamin D Trends Mol. Med. 2010 16 295 302 10.1016/j.molmed.2010.04.005 20488750
Publication and source details

Original title: Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson’s Disease: A Meta-Analysis Assessment

Liang Shen; Hong-Fang Ji

Nutrients · 2015

* Author to whom correspondence should be addressed; E-Mail: jhf@sdut.edu.cn; Tel./Fax: +86-533-278-2220.© 2015 by the authors; licensee MDPI, Basel, Switzerland.2015https://creativecommons.org/licenses/by/4.0/This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T07:12:58.428089+00:00

DOI: 10.3390/nu7064817 · PMC4488816